Skip to main content

Adding calcium to EDTA plasma samples prior to analysis could solve the compatibility issue in commercially available ELISAs that are standardized for serum.

Tenland E, Hillman M

Publication: Clin Chem Lab Med (2013) • Vol 51 • Page e145-7PMID: 23314548View on PubMed

Purpose

The purpose of this paper was to determine the effects of analyzing EDTA plasma rather than serum and adding calcium chloride (CaCl2) to EDTA plasma on results of the quantikine human soluble hemoglobin scavenger receptor (sCD163) ELISA.

Conclusion

While the majority of EDTA plasma specimens assayed by the sCD163 ELISA performed similarly to serum, some EDTA plasma specimens gave significantly higher sCD163 measurements than their serum counterparts. Overnight incubation of EDTA plasma with CaCl2 was able to attenuate the falsely high results so that there was no effective bias between the plasma and corresponding serum specimens.

Studies (1)

Purpose

The purpose of this study was to determine the effects of analyzing EDTA plasma rather than serum and adding CaCl2 to EDTA plasma on results of the quantikine human sCD163 ELISA. The manufacturer recommends against the use of EDTA plasma in this ELISA but claims that it is suitable for use with serum and heparin plasma. Specimens were obtained from 49 diabetic patients and serum and plasma were stored at -20 degrees C until analysis. An aliquot of EDTA plasma was thawed and incubated with CaCl2 overnight at 4 degrees C.

Summary of Findings

While the majority of EDTA plasma specimens assayed by the sCD163 ELISA performed similarly to serum, some EDTA plasma specimens gave significantly higher sCD163 measurements than their serum counterparts. Overnight incubation of EDTA plasma with CaCl2 was able to attenuate the falsely high results so that there was no effective bias between the plasma and corresponding serum specimens.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Diabetes Type 1
    Diabetes Type 2
  • Platforms

    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    EDTA
    None
    Biospecimen Aliquots and ComponentsBiospecimen components
    25 mM CaCl2
    No added CaCl2
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum